Breast Cancer Foundation NZ
Lumina FAPI PET-CT trial
Early Breast Cancer clinical trials for Other
The new clinical trial is recruiting from October 2024 in Auckland, Waikato, Bay of Plenty and Palmerston North. The trial aims to use a newly discovered radioactive tracer called Fibroblast Activation Protein Inhibitor (FAPI) in CT imaging to accurately diagnose and stage lobular breast cancers.
People with lobular breast cancer are encouraged to speak to their medical team about eligibility.
Lobular breast cancer is the second most common type of breast cancer, with around 450 women diagnosed in New Zealand each year. Rather than forming a lump or a mass, lobular breast cancer cells are more unnoticeable as they grow along single layers, making it harder to detect on a mammogram. Complexities in diagnosis and response to treatment mean patients with lobular breast cancer are far likelier to either receive more aggressive treatment than necessary or insufficient treatment, putting them at greater risk of their cancer returning or spreading.
Trial will involve 50 lobular breast cancer patients recruited from around the country who will receive a PET CT scan. The radiotracer FAPI will be used during the scan which binds with cancerous cells to indicate whether the cancer has spread and pinpoint where it has spread to. If there are areas of cancer that haven’t shown up on previous imaging, a radiologist will determine whether the patient was initially incorrectly staged, and the patient’s wider clinical team will assess if a different treatment pathway should be recommended.
New Zealand
Waikato
Bay of Plenty
Palmerston North
If you think you might be a candidate for this trial, use the contact details supplied, or talk to your doctor.
Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at intouch@bcf.org.nz
Similar clinical trials
For Early Breast Cancer
Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to intouch@bcf.org.nz
Interested in a clinical trial?
Subscribe for updates & stay in the loop with new studies.